BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 14752836)

  • 21. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
    Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
    Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic iron loading in patients with compound heterozygous HFE mutations.
    Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP
    Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
    Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
    Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease.
    Lee SH; Jeong SH; Lee D; Lee JH; Hwang SH; Cho YA; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kang W
    J Clin Gastroenterol; 2010 Aug; 44(7):e154-61. PubMed ID: 20216079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hfe mutations and iron overload in patients with alcoholic liver disease.
    Costa-Matos L; Batista P; Monteiro N; Henriques P; Girão F; Carvalho A
    Arq Gastroenterol; 2013; 50(1):35-41. PubMed ID: 23657305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
    Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    Manco M; Alisi A; Real JF; Equitani F; DeVito R; Valenti L; Nobili V
    J Hepatol; 2011 Sep; 55(3):647-653. PubMed ID: 21168460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.
    Dhillon BK; Das R; Garewal G; Chawla Y; Dhiman RK; Das A; Duseja A; Chandak GR
    World J Gastroenterol; 2007 Jun; 13(21):2956-9. PubMed ID: 17589946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
    Won JE; Jeong SH; Chung JI; Lee JH; Hwang SH; Kim JW; Lee SH; Kim N; Park YS; Lee DH; Kim H
    Intervirology; 2009; 52(5):239-46. PubMed ID: 19602897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.